LISA LEDOUX: Open Payments
NPI 1922520972 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 61 payments from 20 companies in 2025. Trend: 2023 $567 · 2024 $1,020 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $211 |
| BridgeBio Pharma, Inc. | 8 | $191 |
| HARMONY BIOSCIENCES LLC | 5 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $130 |
| GlaxoSmithKline, LLC. | 7 | $124 |
| Amgen Inc. | 6 | $98 |
| Novo Nordisk Inc | 3 | $71 |
| Actelion Pharmaceuticals US, Inc. | 3 | $70 |
| Alnylam Pharmaceuticals Inc. | 2 | $43 |
| Verona Pharma, Inc. | 1 | $31 |
Products named: Attruby, VYNDAQEL, WAKIX, JARDIANCE, NUCALA, REPATHA, Wegovy, ELIQUIS.
Industry payments across MA — which companies pay providers there.
